HABS-HD Project 1: Understanding Alzheimer’s Biomarkers in Diverse Communities
Official title: HABS-HD - Project 1
Funded at University of North Texas Hlth Sci Ctr · NIH-11412505 · Data updated 2026-11-12
A large study is looking at Alzheimer’s biomarkers in adults 21 and older across diverse communities to help improve future treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas Hlth Sci Ctr NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project start | September 30, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $404,259 |
| NIH project number | 5U19AG078109-05 |
| Project ID | NIH-11412505 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults 21 years and older, especially from African American and Hispanic communities, who may participate in biomarker studies or contribute data.
✕Less likely to help
Individuals without access to the study sites or who do not meet the biomarker or demographic criteria may not benefit.
What this research studies
This project focuses on how early Alzheimer’s biomarkers appear and behave in African American and Hispanic adults, not just non-Hispanic whites. Researchers will study biomarker patterns across adulthood to see how they relate to the AT(N) framework used in trials. The goal is to make biomarker-based therapies more relevant and effective for communities that have been underrepresented in dementia research. The work will involve community-based data collection and analysis to map biomarker trajectories over time.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and inclusive biomarker-based approaches for diagnosing and treating Alzheimer’s in diverse populations.
How similar studies have gone: Previous biomarker studies have shown promise in NHW populations but underrepresented groups need more validation; this study aims to extend those findings.
Where this research is happening
-
University of North Texas Hlth Sci Ctr
Fort Worth, United States Active
Researchers
- Principal investigator: O'bryant, Sid E — University of North Texas Hlth Sci Ctr
- Study coordinator: O'bryant, Sid E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.